|
|
Post by sportsrancho on Mar 23, 2020 9:55:33 GMT -5
Always nice to have "sideline boy" shooting holes in arguments.𤣠Please supply some accurate sales information cause the rest is just wind in your sails. No argument....simple sales numbers will do. You see thats how investors make decisions. Oh, so "sideline boy" is supposed to be derogatory? I'm quite happy being on the sidelines quite frankly. Have I ever criticised anyone for their strategy? Since Vdex is privately held then you know sales numbers are not available. Do investors also make decisions based on "voodoo" comments? Oh and as you can see, wind in my sails is what I seek wholeheartedly. falcon.... Exactly right! And..... thatâs what they say when they run out of things to argue aboutđâ I want the numbers now!â â Sideline boyâ âShamâ Do I wish I was on the sidelines? absolutely! I wish I had never bought this stock. I wish I never bought any stocks. Until this moment in time, because in a couple weeks Iâm going to buy as many as I can ...including more Mannkind:-) |
|
|
|
Post by morfu on Mar 23, 2020 10:41:51 GMT -5
âVdex is inferior if their treatment cost more per patient.â So a more expensive car is inferior to a less expensive one? Help me with your logic. A $30 oil change or a $60 oil change is a big price disparity, but not compared to a $3000 engine overhaul as a result of not changing the oil at all. Canât get my head around your comment. Your message is confusing and seems off topic
>> So a more expensive car is inferior to a less expensive one?
For some matrix, yes it is, for example miles/$
I keep on wondering why they sell these big phallus symbols.. it always seems to me that USA is full of people who have about $100k to burn every 10years or so..
>> A $30 oil change or a $60 oil change is a big price disparity
Typically that is difference in oil, not labor >> a $3000 engine overhaul
You can buy a fully functional car for 3000$
Are you saying not to treat a medical condition at all?
Most of the difference between a cheap and expensive car in order to get from A to B is just in your head! Same thing for your fancy watch compared to a $5 digital one with an STFS chip.. guess which one does it´s job better.. In the medical business the patches with that little artwork are for children, everything else is gauged by efficiency!
|
|
|
|
Post by morfu on Mar 23, 2020 10:48:59 GMT -5
Oh, so "sideline boy" is supposed to be derogatory? I'm quite happy being on the sidelines quite frankly. Have I ever criticised anyone for their strategy? Since Vdex is privately held then you know sales numbers are not available. Do investors also make decisions based on "voodoo" comments? Oh and as you can see, wind in my sails is what I seek wholeheartedly. falcon.... Exactly right! And..... thatâs what they say when they run out of things to argue aboutđâ I want the numbers now!â â Sideline boyâ âShamâ Do I wish I was on the sidelines? absolutely! I wish I had never bought this stock. I wish I never bought any stocks. Until this moment in time, because in a couple weeks Iâm going to buy as many as I can ...including more Mannkind:-)
>> ...including more Mannkind:-) Good to hear, that´s the spirit!
>> â I want the numbers now!â While this is not exactly what I said, that is kind of the point of this discussion, right? You argue, that Mannkind should do Vdex favors and the critic´s say, why should they do that.
>> another clinic couldnât set up shop within a certain mile radius
sounds like something which might cost Mannkind some business, particular since I expressed my belief, that over time the Vdex-advance for TIR and such will diminish. So if Vdex want that, they should make an offer for it.
|
|
|
|
Post by sportsrancho on Mar 23, 2020 10:59:05 GMT -5
falcon.... Exactly right! And..... thatâs what they say when they run out of things to argue aboutđâ I want the numbers now!â â Sideline boyâ âShamâ Do I wish I was on the sidelines? absolutely! I wish I had never bought this stock. I wish I never bought any stocks. Until this moment in time, because in a couple weeks Iâm going to buy as many as I can ...including more Mannkind:-)
>> ...including more Mannkind:-) Good to hear, that´s the spirit!
>> â I want the numbers now!â While this is not exactly what I said, that is kind of the point of this discussion, right? You argue, that Mannkind should do Vdex favors and the critic´s say, why should they do that.
>> another clinic couldnât set up shop within a certain mile radius
sounds like something which might cost Mannkind some business, particular since I expressed my belief, that over time the Vdex-advance for TIR and such will diminish. So if Vdex want that, they should make an offer for it.
I donât know why weâre even talking about this because that is off the table. Many offers domestically and overseas have been put on the table and buried... and have been posted over and over. Not to say theyâre giving up but you wonât hear about any current ones. |
|
|
|
Post by longliner on Mar 23, 2020 11:29:54 GMT -5
Always nice to have "sideline boy" shooting holes in arguments.𤣠Please supply some accurate sales information cause the rest is just wind in your sails. No argument....simple sales numbers will do. You see thats how investors make decisions. Oh, so "sideline boy" is supposed to be derogatory? I'm quite happy being on the sidelines quite frankly. Have I ever criticised anyone for their strategy? Since Vdex is privately held then you know sales numbers are not available. Do investors also make decisions based on "voodoo" comments? Oh and as you can see, wind in my sails is what I seek wholeheartedly. Vdex is privately held and attempting to gain seats on Mannkind board of directors. Without releasing any sales numbers? Being a private entity does not mean they can't or shouldn't release sales. They sure release the heck out of videos! And yes, I like your avatar. |
|
|
|
Post by sportsrancho on Mar 23, 2020 11:51:51 GMT -5
We donât even know who we have an option to vote for. If you donât like Vdex vote for mnholdem!đ
|
|
|
|
Post by mnholdem on Mar 23, 2020 12:04:18 GMT -5
Considering that I've been an advocate for MannKind improving transparency with stockholders, I suppose that I should disclosed that I was recently informed that MannKind's Board of Directors' Nominations and Governance Committee is still reviewing stockholder-nominated director candidates and that there has been at least one tele-interview with more planned. That's all the information I have on the topic, as of one week ago...  |
|
|
|
Post by agedhippie on Mar 23, 2020 12:24:16 GMT -5
...
>> another clinic couldnât set up shop within a certain mile radius
sounds like something which might cost Mannkind some business, particular since I expressed my belief, that over time the Vdex-advance for TIR and such will diminish. So if Vdex want that, they should make an offer for it. A clinic can set up anywhere in the US and prescribe Afrezza and there is nothing in the world Mannkind can do to stop them even if they wanted to. So what your are suggesting is a non-starter because it's unenforceable (probably why it was never up for discussion in the first place) |
|
|
|
Post by longliner on Mar 23, 2020 12:28:04 GMT -5
We donât even know who we have an option to vote for. If you donât like Vdex vote for mnholdem!đ It's not that I like or dislike Vdex. I simply don't have enough information to know whether they have a viable patient base. To date, Vdex has not been transparent. |
|
|
|
Post by sportsrancho on Mar 23, 2020 12:37:20 GMT -5
We donât even know who we have an option to vote for. If you donât like Vdex vote for mnholdem!đ It's not that I like or dislike Vdex. I simply don't have enough information to know whether they have a viable patient base. To date, Vdex has not been transparent. What do I know, but I doubt that that information is ever going to be posted on a stock board, their obligation is to their investor/funders. If they didnât have a patient base they couldnât get funding or pay salaries or open more clinics. Stay tuned for more new clinic updatesđ |
|
|
|
Post by longliner on Mar 23, 2020 12:39:12 GMT -5
It's not that I like or dislike Vdex. I simply don't have enough information to know whether they have a viable patient base. To date, Vdex has not been transparent. What do I know, but I doubt that that information is ever going to be posted on a stock board, their obligation is to their investor/funders. If they didnât have a patient base they couldnât get funding or pay salaries or open more clinics. Stay tuned for more new clinic updatesđ Sell the heck out of it Sports! |
|
|
|
Post by sportsrancho on Mar 25, 2020 10:36:32 GMT -5
NEXT VIDEO
|
|
|
|
Post by morfu on Mar 25, 2020 11:23:14 GMT -5
He says: give Afreza out for free, dont worry about insurance for now, we are better than everybody else and make me a board member?
Well, again beside your/his shameless advertising for a different company, Mannkind is doing quite well with a more traditional approach! The 90% drop rate cited in that video could be related to the poor coverage for Afrezza at the beginning, I doubt this number is still true!
Whatever Mannkind is doing right now let to a solid increase in numbers over the last two years, there is no reason to change strategies.
Vdex numbers are a big secret, Bill can claim whatever he wants with it, but even if the are true, I am of the opinion, that this advantage might be temporary, since more and more patients learn how properly dose Afrezza without Vdex and they will loose in future competition, since they are more expensive. What skill Bill would add to the board beside "give Afrezza out for free and my clinics an unfair advantage"?
|
|
|
|
Post by sportsrancho on Mar 25, 2020 13:02:32 GMT -5
There is no competition.
Nobody is shamelessly promoting anything, you canât buy shares in Vdex.
This is just one idea of disruptive marketing.
Vdex doesnât buy Afrezza itâs the patients that would get it for free.
Vdex is covered by insurance.. Medi-Cal etc.
|
|
|
|
Post by wgreystone on Mar 25, 2020 14:12:01 GMT -5
The market does not agree that MNKD is doing right now, and the Afrezza sales number does not agree with that too. Can anyone give an example of any other drug's sale growing slower than Afrezza after launching?
|
|
